Country: United States
Language: English
Source: NLM (National Library of Medicine)
NYSTATIN (UNII: BDF1O1C72E) (NYSTATIN - UNII:BDF1O1C72E)
Cosette Pharmaceuticals, Inc.
Nystatin
Nystatin 100000 [USP'U] in 1 g
TOPICAL
PRESCRIPTION DRUG
Nystatin Ointment, USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by Candida albicans and other susceptible Candidaspecies. Nystatin Ointment, USP is not indicated for systemic, oral, intravaginal or ophthalmic use. Nystatin Ointment is contraindicated in patients with a history of hypersensitivity to any of their components.
Nystatin Ointment, USP (100,000 USP Nystatin Units per gram) is a light yellow to yellow ointment available as follows: NDC 0713-0686-15 15 gram tube NDC 0713-0686-31 30 gram tube Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Distributed by: Cosette Pharmaceuticals, Inc. South Plainfield, NJ 07080 8-0686CPLNC3 Rev.03/2022 VC7623
Abbreviated New Drug Application
NYSTATIN- NYSTATIN OINTMENT OINTMENT COSETTE PHARMACEUTICALS, INC. ---------- NYSTATIN OINTMENT, USP 100,000 USP NYSTATIN UNITS P ER GRAM FOR TOPICAL USE ONLY.NOT FOR OPHTHALMIC USE. RX ONLY DESCRIPTION Nystatin Ointment, USP is for dermatologic use. Nystatin Ointment, USP for topical use only, contains 100,000 USP nystatin units per gram, in a white petrolatum base. Nystatin is a polyene antifungal antibiotic drug obtained from _Streptomyces nursei_. The structural formula is as follows: Molecular Weight 926.13 Molecular Formula C H NO CLINICAL PHARMACOLOGY PHARMACOKINETICS Nystatin is not absorbed from intact skin or mucous membrane. MICROBIOLOGY Nystatin is an antibiotic which is both fungistatic and fungicidal _in vitro_against a wide variety of yeasts and yeast-like fungi, including _Candida albicans, C. parapsilosis, C._ _tropicalis, C. guilliermondi, C. pseudotropicalis, C. krusei, Torulopsis glabrata, Tricophyton_ 47 75 17 _rubrum, T. mentagrophytes._ Nystatin acts by binding to sterols in the cell membrane of susceptible species resulting in a change in membrane permeability and the subsequent leakage of intracellular components. On repeated subculturing with increasing concentrations of nystatin, _Candida albicans_does not develop resistance to nystatin. Generally, resistance to nystatin does not develop during therapy. However, other species of _Candida_( _C._ _tropicalis, C. guilliermondi, C. krusei, and C. stellatoides_) become quite resistant on treatment with nystatin and simultaneously become cross resistant to amphotericin as well. This resistance is lost when the antibiotic is removed. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses. INDICATIONS AND USAGE Nystatin Ointment, USP is indicated in the treatment of cutaneous or mucocutaneous mycotic infections caused by _Candidaalbicans_and other susceptible Candidaspecies. NYSTATIN OINTMENT, USP IS NOT INDICATED FOR SYSTEMIC, ORAL, INTRAVAGINAL OR OPHTHALMIC USE. CONTRAINDICATIONS Nystatin Ointment is contraindicated Read the complete document